"Once these kids have Type 2 diabetes, they seem to be at very high risk for early complications when compared to adults," said Jane Lynch, M.D., professor of pediatric endocrinology in the School of Medicine at The University of Texas Health Science Center at San Antonio.
The study, led in San Antonio by UT Medicine pediatricians, includes 699 children and young people, with 44 San Antonio participants.
The rise in youth obesity rates has been accompanied by increasing Type 2 diabetes rates in young people. "It's really a public health issue," said Dr. Lynch, who is principal investigator in the San Antonio arm of the study.
There are many unanswered questions and few guidelines for treatment of youth with early onset Type 2 diabetes, she said. Type 2 diabetes should not be confused with Type 1 diabetes, formerly called juvenile diabetes.
Of the TODAY participants, more than a third required medication for hypertension or kidney disease 3.9 years after they had joined the study. In the study, published online Thursday afternoon in Diabetes Care, 699 adolescents were randomized into three groups that received metformin, metformin plus rosiglitazone, or metformin plus intensive lifestyle intervention.
While the children on the combined drugs did the best of the three groups, Dr. Lynch said, all did poorly. The researchers were particularly disappointed that the intensive lifestyle intervention group did not do better.
The rate of deterioration of beta cell function in youth was almost four times higher than in adults, researchers found, noting a 20-35 percent decline in beta cell function per year on average, compared to 7-11 percent for adults. Beta cells store and release insulin.
It does not make things easier that these adolescents with early onset T2 diabetes have a tough time managing complex health problems.
"In puberty, everyone becomes somewhat insulin-resistant … and when you're insulin-resistant you're hungry, plus when you have diabetes you're thirsty. This becomes a huge issue when there's the tendency to make poor choices."One sobering aspect of the study results is that the young patients all had to fit certain health parameters, such as not having high blood pressure or having a treatable level of high blood pressure, and they all received the best possible care, education and medical support.
"That's Cadillac treatment for any kids with diabetes — and we still had these outcomes," Dr. Lynch said.
Despite the interventions in all three treatment arms, the kids kept getting sicker. Boys and girls both developed kidney disease at about the same rates, but obese teenage boys were 81 percent more likely to develop hypertension, Dr. Lynch said. "What's especially challenging for these children is that many also develop fatty liver, which limits our use of the drugs that control hypertension."
The study will continue as researchers monitor the participants' overall outcomes, including cardiac health. "Our goal is to follow them for 10 or 15 years as we figure out better ways to prevent this disease and how to predict complications," Dr. Lynch said.
All the educational handouts used in the study are available free online at https://today.bsc.gwu.edu/web/today/tsdematerials. The study was funded in part by NIDD/NIH, grant no. U01-DK-61230.
For current news from the UT Health Science Center San Antonio, please visit our news release website or follow us on Twitter @uthscsa.
Elizabeth Allen | EurekAlert!
New discoveries predict ability to forecast dementia from single molecule
12.12.2018 | UT Southwestern Medical Center
Pain: Perception and motor impulses arise in the brain independently of one another
12.12.2018 | Technische Universität München
What if, instead of turning up the thermostat, you could warm up with high-tech, flexible patches sewn into your clothes - while significantly reducing your...
A widely used diabetes medication combined with an antihypertensive drug specifically inhibits tumor growth – this was discovered by researchers from the University of Basel’s Biozentrum two years ago. In a follow-up study, recently published in “Cell Reports”, the scientists report that this drug cocktail induces cancer cell death by switching off their energy supply.
The widely used anti-diabetes drug metformin not only reduces blood sugar but also has an anti-cancer effect. However, the metformin dose commonly used in the...
A research team from the University of Zurich has developed a new drone that can retract its propeller arms in flight and make itself small to fit through narrow gaps and holes. This is particularly useful when searching for victims of natural disasters.
Inspecting a damaged building after an earthquake or during a fire is exactly the kind of job that human rescuers would like drones to do for them. A flying...
Over the last decade, there has been much excitement about the discovery, recognised by the Nobel Prize in Physics only two years ago, that there are two types...
What if a sensor sensing a thing could be part of the thing itself? Rice University engineers believe they have a two-dimensional solution to do just that.
Rice engineers led by materials scientists Pulickel Ajayan and Jun Lou have developed a method to make atom-flat sensors that seamlessly integrate with devices...
12.12.2018 | Event News
10.12.2018 | Event News
06.12.2018 | Event News
13.12.2018 | Physics and Astronomy
13.12.2018 | Earth Sciences
13.12.2018 | Life Sciences